CD274 and cancer: Theoretical framework = not mentionedSetting = 3 cancer centersPopulation = mixed advanced cancersSample size = 37Median age = 62 yFemale = 27%Race and ethnicity = not mentionedTreatment type = anti–PD-L1 agents